Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,155,000 | 5,017,000 | 2,381,000 | 9,168,000 | 7,932,000 |
| Depreciation Amortization | 3,733,000 | 2,461,000 | 1,260,000 | 5,537,000 | 4,206,000 |
| Income taxes - deferred | -165,000 | -183,000 | -41,000 | 317,000 | 766,000 |
| Accounts receivable | N/A | N/A | N/A | 148,000 | N/A |
| Other Working Capital | -1,297,000 | -1,879,000 | -1,883,000 | 1,623,000 | -1,519,000 |
| Other Operating Activity | 364,000 | -646,000 | -1,037,000 | 291,000 | 100,000 |
| Operating Cash Flow | $9,790,000 | $4,770,000 | $680,000 | $17,084,000 | $11,485,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,098,000 | 7,474,000 | 8,399,000 | 350,000 | 1,534,000 |
| PPE Investments | -786,000 | -497,000 | -239,000 | -1,199,000 | -845,000 |
| Net Acquisitions | -16,322,000 | -679,000 | -678,000 | -195,000 | -195,000 |
| Purchase Of Investment | -6,578,000 | -5,422,000 | -3,150,000 | -10,718,000 | -9,254,000 |
| Sale Of Investment | 4,535,000 | 3,291,000 | 1,937,000 | 6,145,000 | 4,637,000 |
| Purchase Sale Intangibles | -48,000 | -12,000 | -7,000 | -384,000 | -342,000 |
| Other Investing Activity | 297,000 | 320,000 | 323,000 | -37,000 | -17,000 |
| Investing Cash Flow | $-756,000 | $4,487,000 | $6,592,000 | $-5,654,000 | $-4,140,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,929,000 | 2,503,000 | 2,862,000 | -1,828,000 | -2,750,000 |
| Debt Issued | N/A | N/A | N/A | 4,491,000 | 4,491,000 |
| Debt Repayment | -2,994,000 | -2,995,000 | -2,998,000 | -2,110,000 | -786,000 |
| Common Stock Issued | 1,165,000 | 981,000 | 794,000 | 1,002,000 | 704,000 |
| Common Stock Repurchased | -6,160,000 | -6,000,000 | -6,000,000 | -5,000,000 | -3,801,000 |
| Dividend Paid | -5,211,000 | -3,483,000 | -1,758,000 | -6,609,000 | -4,970,000 |
| Other Financing Activity | 156,000 | 142,000 | 122,000 | -133,000 | 52,000 |
| Financing Cash Flow | $-9,115,000 | $-8,852,000 | $-6,978,000 | $-10,187,000 | $-7,060,000 |
| Exchange Rate Effect | -162,000 | -78,000 | -74,000 | -83,000 | -30,000 |
| Beginning Cash Position | 3,343,000 | 3,343,000 | 3,343,000 | 2,183,000 | 2,183,000 |
| End Cash Position | 3,099,000 | 3,670,000 | 3,563,000 | 3,343,000 | 2,437,000 |
| Net Cash Flow | $-244,000 | $327,000 | $220,000 | $1,160,000 | $255,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,790,000 | 4,770,000 | 680,000 | 17,084,000 | 11,485,000 |
| Capital Expenditure | -786,000 | -497,000 | -239,000 | -1,199,000 | -845,000 |
| Free Cash Flow | 9,004,000 | 4,273,000 | 441,000 | 15,885,000 | 10,640,000 |